Globe Life (NYSE:GL) CEO Frank Svoboda Sells 9,379 Shares

Globe Life Inc. (NYSE:GL) CEO Frank Svoboda sold 9,379 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the transaction, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,036,943.24. The trade was a 20.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Globe Life Stock Down 0.4%

GL stock opened at $138.16 on Thursday. Globe Life Inc. has a twelve month low of $104.06 and a twelve month high of $147.83. The stock has a 50-day simple moving average of $134.13 and a two-hundred day simple moving average of $132.93. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $11.00 billion, a PE ratio of 10.02 and a beta of 0.48.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.54 by $0.27. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. The company had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.52 billion. During the same period in the previous year, the business earned $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. On average, equities analysts predict that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Monday, January 5th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Monday, January 5th. Globe Life’s dividend payout ratio (DPR) is presently 7.83%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in GL. AdvisorNet Financial Inc grew its holdings in shares of Globe Life by 60.0% during the 2nd quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock worth $28,000 after purchasing an additional 84 shares during the period. Intech Investment Management LLC lifted its stake in shares of Globe Life by 0.8% in the second quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock worth $1,438,000 after acquiring an additional 95 shares in the last quarter. CX Institutional boosted its stake in shares of Globe Life by 5.6% during the 3rd quarter. CX Institutional now owns 1,805 shares of the company’s stock valued at $258,000 after buying an additional 96 shares during the last quarter. Laird Norton Wetherby Wealth Management LLC boosted its stake in Globe Life by 2.2% during the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after acquiring an additional 99 shares during the last quarter. Finally, KLP Kapitalforvaltning AS grew its stake in Globe Life by 0.5% in the third quarter. KLP Kapitalforvaltning AS now owns 22,000 shares of the company’s stock worth $3,145,000 after purchasing an additional 100 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Morgan Stanley reaffirmed an “overweight” rating and issued a $176.00 price target on shares of Globe Life in a research report on Monday. Keefe, Bruyette & Woods increased their price target on Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a report on Tuesday, October 28th. Truist Financial raised their price objective on shares of Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a report on Friday, October 24th. Wells Fargo & Company lowered their target price on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Globe Life in a report on Monday. Nine equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and an average target price of $164.89.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.